Osteosarcoma — Trials

Osteosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

349 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 99
Recruiting: 58
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04571229	Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma	available	—	—	Memorial Sloan Kettering Cancer CenterOTHER	1	May 11, 2026	clinicaltrials
NCT04091295	BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast	available	—	—	Aveni FoundationOTHER	1	Mar 4, 2026	clinicaltrials